15 May 2018
San Mateo, CA – May 1, 2018: Adherium, an award-winning digital health company that improves medication adherence and patient outcomes, today announced the Company will be participating in the upcoming Chardan Digital Health Conference in San Francisco, CA on Tuesday, May 22, 2018.
Arik Anderson, CEO, is scheduled to provide a business overview on the Company, its leadership in respiratory medication adherence, and upcoming entry into the U.S. market at 10:00am Pacific Time. In addition, Mr. Anderson will be speaking on a panel entitled: Sensors are Enabling Advanced Care and New Business Models at 11:45am Pacific Time.
Members of the investment community that are interested in attending can find additional detail on the Chardan Research website at www.chardan.com.
Adherium’s SmartInhaler™ solution is designed to help patients achieve better adherence. It provides people who live with asthma or COPD with the tools to manage their condition and empowers them to take control of their health day by day. It operates by tracking medication use and reminding the user when to take doses. The platform-based solution has been built on evidence from more than 72 peer reviewed studies and the experiences drawn from more than 100,000 devices distributed.
Adherium is a provider of digital health solutions and a global leader in connected respiratory medical devices, with over 100,000 devices distributed globally. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of connected medical devices for respiratory medications. The devices and accompanying technology address sub-optimal medication use and strive to improve health outcomes in chronic disease. Adherium is headquartered in the U.S., and operates globally from bases in the U.S., Europe and Australasia. Learn more at adherium.com.
Vik Panda, Adherium
Chris Gale, Greentarget
Leigh Salvo, Gilmartin Group